Increasing anti-S antibody testing: a quality improvement initiative with evolving COVID-19 guidelines

BMJ Open Quality

article

Ali M Alam¹  Rebecca Lester²  Marie-Claire Hoyle²  Tom E Fletcher²  Paul Hine² 

[1] Institute of Infection, Veterinary and Ecological Sciences , University of Liverpool;Tropical and Infectious Diseases Unit , Royal Liverpool University Hospital;Liverpool School of Tropical Medicine

关键词: COVID-19;    Quality improvement;    Quality measurement;   

DOI  :  10.1136/bmjoq-2022-001886

学科分类：药学

来源: BMJ Publishing Group

【 摘 要 】

Background COVID-19 management guidelines are constantly evolving, making them difficult to implement practically. Ronapreve was a neutralising monoclonal antibody introduced into UK COVID-19 guidelines in 2021. It reduces mortality in seronegative patients infected with non-omicron variants. Antibody testing on admission is therefore vital in ensuring patients could be considered for Ronapreve as inpatients.Local problem We found that on our COVID-19 ward, 31.4% of patients were not having anti-S tests despite fulfilling the other criteria to be eligible for Ronapreve. This was identified as an important target to improve; by not requesting anti-S tests, we were forgoing the opportunity to use an intervention that could improve outcomes.Methods We analysed patient records for patients with COVID-19 admitted to our ward over 4 months to observe if awareness of the need to request anti-S increased through conducting plan–do–study–act (PDSA) cycles.Interventions Our first intervention was an multidisciplinary team (MDT) discussion at our departmental audit meeting highlighting our baseline findings and the importance of anti-S requesting. Our second intervention was to hang printed posters in both the doctors’ room and the ward as a visual reminder to staff. Our final intervention was trust-wide communications of updated local COVID-19 guidance that included instructions for anti-S requesting on admission.Results Our baseline data showed that only 68.6% of patients with symptomatic COVID-19 were having anti-S antibody tests requested. This increased to 95.0% following our three interventions. There was also a reduction in the amount of anti-S requests being ‘added on’, from 57.1% to 15.8%.Conclusions COVID-19 guidelines are constantly evolving and require interventions that can be quickly and easily implemented to improve adherence. Sustained reminders through different approaches allowed a continued increase in requesting. This agrees with research that suggests a mixture of educational sessions and visual reminders of guidelines increase their application in clinical practice.

【 授权许可】

CC BY-NC|CC BY|CC BY-NC-ND